Integer Holdings Corporation Common Stock (ITGR)

FairStock Score: 53/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a Buffett/Graham-style investor, I look for a durable business bought at a sensible price. Integer is a medical device contract developer and manufacturer with 11,000 employees, serving interventional cardiology, cardiac rhythm management, and other procedure areas. That niche can have switching costs and regulatory stickiness, but the numbers do not yet show a wide moat. Return on equity was 7.50% and return on capital employed 3.86%, both modest, while debt-to-equity is 0.79. Free cash flow over the trailing twelve months was $112.0M, only a 2.6% FCF yield on the $4.3B market cap. Growth has been uneven. In fiscal Q2 2026, the quarter ended 2026-07-03, revenue was $464.1M, net income $23.6M, and diluted EPS $0.69. That compares poorly with fiscal Q2 2025, when revenue was $476.5M, net income $37.0M, and diluted EPS $1.04. For FY2025, revenue was $1.9B, net income $102.8M, and diluted EPS $2.89, versus FY2024 revenue of $1.7B, net income of $119.9M, and diluted EPS of $3.36. So sales rose but profit fell. FairStock classifies it as a SLOW GROWER, with profit up 5.9% a year over five years and revenue up 11.5%. At the 2026-10-13 close of $126.59, the FairStock P/E is 34.68, price-to-book 2.50, EV/EBITDA 18.47, and the Graham Number is $64.44, giving a margin of safety of -96.45%. The Piotroski F-score is 7/9, and Altman Z is 2.32. The stock is near its 52-week high of $126.80, but the price seems to demand much better execution than the recent filings show.

In plain English: Integer Holdings makes medical devices and parts for other healthcare companies. It is profitable and generates cash, but profits dropped in the latest quarter and the company earns little on the money it invests. At the 2026-10-13 closing price of $126.59, the stock looks expensive compared with its profits and assets.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-07-03) · fiscal Q1 2026 10-Q (period ended 2026-04-03) · fiscal Q3 2025 10-Q (period ended 2025-09-26) · fiscal Q2 2025 10-Q (period ended 2025-06-27) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer